Published November 8, 2022 | Version Accepted Version

Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction

Description

This is the accepted manuscript version of the work published in its final form as Steytler, J., Craig, C., Ryst, E. V. D., Baelen, B. V., Nuttall, J., Niekerk, N. V., Mellors, J., Parikh, U., Wallis, C., & . (2023). Characterization of viruses in phase 3 and phase 3b trials (the ring study and the dapivirine ring extended access and monitoring trial) of the dapivirine vaginal ring for human immunodeficiency virus type 1 infection risk reduction. Clinical Infectious Diseases, 76(6), 996-1002. https://doi.org/10.1093/cid/ciac875

Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Files

IPM_007_Manuscript_18Sep2022.pdf

Files (313.5 kB)

Name Size
md5:216d74613f5ae37d2d2cdbb3ca7bc7a8
313.5 kB Preview Download

Additional details

Related works

Is identical to
10.1093/cid/ciac875 (DOI)